You are about to leave this site and are being redirected to another site. Would you like to leave this site?

BAVENCIO® (avelumab) is a prescription medicine used to treat a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children 12 years of age and older. BAVENCIO may be used when your skin cancer has spread. 

This indication is approved under accelerated approval based on a clinical trial that measured how many patients responded and how long they responded. Continued approval may depend on benefit demonstrated in ongoing clinical trials.

It is not known if BAVENCIO is safe and effective in children under the age of 12.

For Patients With Merkel Cell Carcinoma That Has Spread

BAVENCIO® (avelumab) is a prescription medicine used to treat a type of cancer in the bladder or urinary tract called urothelial cancer (UC). BAVENCIO may be used when your cancer has spread or cannot be removed by surgery (advanced UC), and you have received chemotherapy that contains platinum and it did not work or is no longer working. 

This indication is approved under accelerated approval based on a clinical trial that measured how many patients responded and how long they responded. Continued approval may depend on benefit demonstrated in ongoing clinical trials.

It is not known if BAVENCIO is safe and effective in children under the age of 12.

For Certain Previously Treated Patients With a Type of Cancer in the Bladder or Urinary Tract Called Urothelial Cancer That Has Spread or Cannot Be Removed by Surgery 

BAVENCIO® (avelumab) is a prescription medicine used to treat a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children 12 years of age and older. BAVENCIO may be used when your skin cancer has spread. 

This indication is approved under accelerated approval based on a clinical trial that measured how many patients responded and how long they responded. Continued approval may depend on benefit demonstrated in ongoing clinical trials.

It is not known if BAVENCIO is safe and effective in children under the age of 12.

LEARN MORE

BAVENCIO® (avelumab) is a prescription medicine used to treat a type of cancer in the bladder or urinary tract called urothelial cancer (UC). BAVENCIO may be used when your cancer has spread or cannot be removed by surgery (advanced UC), and you have received chemotherapy that contains platinum and it did not work or is no longer working. 

This indication is approved under accelerated approval based on a clinical trial that measured how many patients responded and how long they responded. Continued approval may depend on benefit demonstrated in ongoing clinical trials.

It is not known if BAVENCIO is safe and effective in children under the age of 12.

LEARN MORE

Questions about access and support? Learn how CoverOne® may help.